Wednesday, June 22, 2016
- 12:00pm-1:30pm
-
Staging of cognitive impairment: Validation of a novel cognitive score with [18F]FDG-PET
Parkinson's disease: Cognition · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Standardized assessment of camptocormia in idiopathic Parkinson’s disease
Phenomenology and clinical assessment of movement disorders · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Strategies for a high quality data in an observational longitudinal study: Enroll-HD experience
Huntington's disease · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Striatal molecular alterations in Huntington’s disease gene expansion carriers: A systematic review and meta-analysis of PET studies
Huntington's disease · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
STUB1/CHIP mutations cause Gordon Holmes syndrome as part of widespread multisystemic neurodegeneration: Evidence from novel mutations
Ataxia · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Study of striatal dopamine transporter function in Alzheimer’s disease with parkinsonism
Cognitive disorders · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Sub-acute rapidly progressive cerebellar ataxia – A case of JC virus associated granule cell neuronopathy (GCN)
Ataxia · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Substantia nigra hyperechogenicity in Mexican patients with Parkinson’s disease
Parkinson's disease: Neuroimaging and neurophysiology · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Substantia nigra hyperechogenicity in Parkinson´s disease motor phenotypes
Parkinson's disease: Neuroimaging and neurophysiology · Exhibit Hall located in Hall B, Level 2
- «Previous Page
- 1
- …
- 43
- 44
- 45
- 46
- 47
- …
- 54
- Next Page»